{"id":62418,"date":"2025-07-03T10:00:47","date_gmt":"2025-07-03T08:00:47","guid":{"rendered":"https:\/\/ticker-noticiasep.microcontenidos.com\/NoticiaRSS.vbhtml?user=FRND562DLP&amp;cod=20250703100047"},"modified":"2025-07-03T10:00:47","modified_gmt":"2025-07-03T08:00:47","slug":"mundo-avanzando-en-salud-osea-la-comision-europea-autoriza-los-biosimilares-de-denosumab-de-biocon-biologics-2","status":"publish","type":"post","link":"https:\/\/webciudadana.net\/?p=62418","title":{"rendered":"Mundo: Avanzando en Salud \u00d3sea: La Comisi\u00f3n Europea Autoriza los Biosimilares de Denosumab de Biocon Biologics (2)"},"content":{"rendered":"\n<p>(Informaci\u00f3n remitida por la empresa firmante)<\/p>\n<p>\n[6] https:\/\/orthoinfo.aaos.org\/en\/diseases&#8211;conditions\/giant-cell-tumor-of-bone\/[7] https:\/\/www.bcrt.org.uk\/information\/information-by-type\/giant-cell-tumor\/<\/p>\n<p>\n[8] https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2405844024069214#:~:text=Epidemiology,reportedly%20higher%20in%20Asian%20populations<\/p>\n<p>\nLogo &#8212; https:\/\/mma.prnewswire.com\/media\/2724007\/5399163\/Biocon_Biologics_Logo.jpg<\/p>\n<p> View original content:https:\/\/www.prnewswire.com\/news-releases\/avanzando-en-salud-osea-la-comision-europea-autoriza-los-biosimilares-de-denosumab-de-biocon-biologics-302497327.html<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(Informaci\u00f3n remitida por la empresa firmante) [6] https:\/\/orthoinfo.aaos.org\/en\/diseases&#8211;conditions\/giant-cell-tumor-of-bone\/[7] https:\/\/www.bcrt.org.uk\/information\/information-by-type\/giant-cell-tumor\/ [8] https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2405844024069214#:~:text=Epidemiology,reportedly%20higher%20in%20Asian%20populations Logo &#8212; https:\/\/mma.prnewswire.com\/media\/2724007\/5399163\/Biocon_Biologics_Logo.jpg View original content:https:\/\/www.prnewswire.com\/news-releases\/avanzando-en-salud-osea-la-comision-europea-autoriza-los-biosimilares-de-denosumab-de-biocon-biologics-302497327.html<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"class_list":["post-62418","post","type-post","status-publish","format-standard","hentry","category-noticias"],"_links":{"self":[{"href":"https:\/\/webciudadana.net\/index.php?rest_route=\/wp\/v2\/posts\/62418","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/webciudadana.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/webciudadana.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/webciudadana.net\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/webciudadana.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=62418"}],"version-history":[{"count":0,"href":"https:\/\/webciudadana.net\/index.php?rest_route=\/wp\/v2\/posts\/62418\/revisions"}],"wp:attachment":[{"href":"https:\/\/webciudadana.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=62418"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/webciudadana.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=62418"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/webciudadana.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=62418"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}